Stay updated on CAB-AXL-ADC in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.

Latest updates to the CAB-AXL-ADC in Sarcoma Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov page remains a 403 Forbidden error page. Its footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedCore study details and associated metadata were removed from the page, including design and eligibility information and listed locations. This reduces visible information about how the study is conducted and where it takes place.SummaryDifference19%

- Check31 days agoChange DetectedRevision: v3.7.0 replaces Revision: v3.6.6 in the Study Record Dates, signaling an update to the study record's revision tag. This appears to be an administrative update rather than changing core trial data visible to users.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a small site update without changes to the study details or visible content.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous v3.6.4, signaling a newer version of the site. It appears to be a background template/content-management update rather than changes to the study details visible on the page.SummaryDifference0.0%

- Check81 days agoChange DetectedThe revision label was updated from v3.6.3 to v3.6.4, indicating a small backend or interface update rather than a content modification.SummaryDifference0.0%

Stay in the know with updates to CAB-AXL-ADC in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAB-AXL-ADC in Sarcoma Clinical Trial page.